Cell Lysis And Disruption Market Size, Share & Trends Analysis Report By Technique, By Product, By Cell Type (Mammalian Cells, Bacterial Cells, Yeast/Algae/Fungi, Plant Cells), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Cell Lysis And Disruption Market Size, Share & Trends Analysis Report By Technique, By Product, By Cell Type (Mammalian Cells, Bacterial Cells, Yeast/Algae/Fungi, Plant Cells), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030


Cell Lysis And Disruption Market Growth & Trends


The global cell lysis and disruption market size is expected to reach USD 9.63 billion by 2030, registering a CAGR of 8.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The anticipated revenue growth is attributed to accelerating the adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other animal-based recombinant products. Technological developments in procedures involved in releasing cellular organelles have paved the way for the higher adoption of cell disruption methods.

As retrieval and purification of biopharmaceuticals involve cell disruption, a rise in demand for biopharma would lead to the subsequent growth of the market. In addition, advancements in the field of proteomics, metabolomics, and personalized medicine are expected to fuel progressive changes in this sector. However, the high costs of equipment coupled with the dearth of skilled professionals are expected to restrain revenue generation to a certain extent. The restraint can be addressed as the government organizations are releasing substantial funds to support development in the biotechnology sector.

Enzymatic lysis, owing to higher biological specificity, is likely to register the fastest CAGR over the forecast period. Manufacturers are embracing the trend of providing synthetic enzymes and pre-formulated kits, which can be used for the extraction and purification of proteins, DNA, and RNA. Sonication instruments in the products available are expected to witness lucrative growth due to higher adoption rates as a result of the reliability on these instruments. Factors attributing to this reliability include complete control allowed on parameters and negligible maintenance.

Among the physical methods, the high product yield obtained by sonication of the liquid sample is attributed to the larger revenue share of the ultrasonic homogenization method/technique. Asia Pacific will be the fastest-growing regional market from 2021 to 20285 due to lucrative opportunities offered by emerging nations, which has attracted investments from global firms in the region. Key companies are engaged in new product development and strategic alliances to maintain their market share.

Cell Lysis And Disruption Market Report Highlights

  • A rise in the development of biologics has subsequently led to high demand for better bioprocess solutions
  • The reagents & consumables segment is the most widely used segment, and it is estimated to advance at a significant CAGR during the forecast period
  • The advantages include an unaltered biological activity of the sample of interest and ideal compatibility with the laboratory reagents
  • Therefore, key players have developed different detergent-based solutions and buffers, to provide the best possible results for particular tissue types
  • Mammalian cell culture systems have grabbed substantial attention among biopharmaceutical manufacturers, thus leading to higher demand for cell lysis protocols for the same
  • The pharmaceutical & biotechnology companies segment accounted for the largest market revenue share of 36.5% in 2022
  • Substantial research in the development of nucleic-acid derived products is expected to drive progress in this application in the coming years
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technique
1.1.2. Product
1.1.3. Cell type
1.1.4. Application
1.1.5. End use
1.1.6. Regional forecast
1.1.7. Estimates and Forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technique outlook
2.2.2. Product outlook
2.2.3. Cell type outlook
2.2.4. Application outlook
2.2.5. End use outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Cell Lysis and Disruption Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Cell Lysis and Disruption Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Cell Lysis and Disruption Market: Technique Estimates & Trend Analysis
4.1. Cell Lysis and Disruption Market, By Technique Key Takeaways
4.2. Cell Lysis and Disruption Market: Technique Movement & Market Share Analysis, 2022 & 2030
4.3. Reagent-Based
4.3.1. Reagent based market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Detergent
4.3.2.1. Detergent market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Enzymatic
4.3.3.1. Enzymatic market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Physical Disruption
4.4.1. Physical disruption market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Mechanical homogenization
4.4.2.1. Mechanical homogenization market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Ultrasonic homogenization
4.4.3.1. Ultrasonic homogenization market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Pressure homogenization
4.4.4.1. Pressure homogenization market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5. Temperature treatments
4.4.5.1. Temperature treatments market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cell Lysis and Disruption Market: Product Estimates & Trend Analysis
5.1. Cell Lysis and Disruption Market: Key Takeaways
5.2. Cell Lysis and Disruption Market: Product Movement & Market Share Analysis, 2022 & 2030
5.3. Instruments
5.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.2. High pressure homogenizers
5.3.2.1. High Pressure Homogenizers market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.3. Sonicator
5.3.3.1. Sonicator market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.4. French press
5.3.4.1. French press market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.5. Microfluidizer
5.3.5.1. Microfluidizer market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.6. Bead mill
5.3.6.1. Bead mill market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.7. Other instruments
5.3.7.1. Other instruments market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Reagents and Consumables
5.4.1. Reagents and consumables market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Enzymes
5.4.2.1. Enzymes market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3. Detergent solutions
5.4.3.1. Detergent solutions market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3.2. Ionic detergent
5.4.3.2.1. Ionic detergent market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3.3. Nonionic detergent
5.4.3.3.1. Nonionic detergent market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3.4. Zwitterionic detergent
5.4.3.4.1. Zwitterionic detergent market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.4. Kits & reagents
5.4.4.1. Kits & reagents market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Cell Lysis and Disruption Market: Cell Type Estimates & Trend Analysis
6.1. Cell Lysis and Disruption Market: Key Takeaways
6.2. Cell Lysis and Disruption Market: Cell Type Movement & Market Share Analysis, 2022 & 2030
6.3. Mammalian Cells
6.3.1. Mammalian cells market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Bacterial Cells
6.4.1. Bacterial cells market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Yeast/Algae/Fungi
6.5.1. Yeast/Algae/Fungi market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Plant Cells
6.6.1. Plant cells market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Cell Lysis and Disruption Market: Application Estimates & Trend Analysis
7.1. Cell Lysis and Disruption Market: Key Takeaways
7.2. Cell Lysis and Disruption Market: Application Movement & Market Share Analysis, 2022 & 2030
7.3. Protein Isolation
7.3.1. Protein isolation market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Downstream Processing
7.4.1. Downstream processing market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Cell Organelle Isolation
7.5.1. Cell organelle isolation market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Nucleic Acid Isolation
7.6.1. Nucleic acid isolation market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Cell Lysis and Disruption Market: End Use Estimates & Trend Analysis
8.1. Cell Lysis and Disruption Market: Key Takeaways
8.2. Cell Lysis and Disruption Market: End-use Movement & Market Share Analysis, 2022 & 2030
8.3. Academic and Research Institutes
8.3.1. Academic and research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
8.4. Hospitals and Diagnostic Labs
8.4.1. Hospitals and diagnostic labs market estimates and forecasts, 2018 to 2030 (USD Million)
8.5. Cell Banks
8.5.1. Cell banks market estimates and forecasts, 2018 to 2030 (USD Million)
8.6. Pharmaceutical and Biotechnology Companies
8.6.1. Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. Cell Lysis and Disruption Market: Regional Estimates & Trend Analysis
9.1. Regional Outlook
9.2. Cell Lysis and Disruption Market by Region: Key Marketplace Takeaways
9.3. North America
9.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.3.2. U.S.
9.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.3.3. Canada
9.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4. Europe
9.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.2. UK
9.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.3. Germany
9.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.4. France
9.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.5. Italy
9.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.6. Spain
9.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.7. Sweden
9.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.8. Norway
9.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.9. Denmark
9.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.2. Japan
9.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.3. China
9.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.4. India
9.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.5. Australia
9.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.6. Thailand
9.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.7. South Korea
9.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6. Latin America
9.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6.2. Brazil
9.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6.3. Mexico
9.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6.4. Argentina
9.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7. MEA
9.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.3. South Africa
9.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.4. UAE
9.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.5. Kuwait
9.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.2.1. Thermo Fisher Scientific, Inc.
10.2.1.1. Company overview
10.2.1.2. Financial performance
10.2.1.3. Product benchmarking
10.2.1.4. Strategic initiatives
10.2.2. Merck KGaA
10.2.2.1. Company overview
10.2.2.2. Financial performance
10.2.2.3. Product benchmarking
10.2.2.4. Strategic initiatives
10.2.3. Bio-Rad Laboratories, Inc.
10.2.3.1. Company overview
10.2.3.2. Financial performance
10.2.3.3. Product benchmarking
10.2.3.4. Strategic initiatives
10.2.4. F. Hoffmann-La Roche Ltd.
10.2.4.1. Company overview
10.2.4.2. Financial performance
10.2.4.3. Product benchmarking
10.2.4.4. Strategic initiatives
10.2.5. QIAGEN
10.2.5.1. Company overview
10.2.5.2. Financial performance
10.2.5.3. Product benchmarking
10.2.5.4. Strategic initiatives
10.2.6. Danaher
10.2.6.1. Company overview
10.2.6.2. Financial performance
10.2.6.3. Product benchmarking
10.2.6.4. Strategic initiatives
10.2.7. Miltenyi Biotec
10.2.7.1. Company overview
10.2.7.2. Financial performance
10.2.7.3. Product benchmarking
10.2.7.4. Strategic initiatives
10.2.8. Claremont BioSolutions, LLC
10.2.8.1. Company overview
10.2.8.2. Financial performance
10.2.8.3. Product benchmarking
10.2.8.4. Strategic initiatives
10.2.9. IDEX
10.2.9.1. Company overview
10.2.9.2. Financial performance
10.2.9.3. Product benchmarking
10.2.9.4. Strategic initiatives
10.2.10. Parr Instrument Company
10.2.10.1. Company overview
10.2.10.2. Financial performance
10.2.10.3. Product benchmarking
10.2.10.4. Strategic initiatives
10.2.11. Covaris, LLC
10.2.11.1. Company overview
10.2.11.2. Financial performance
10.2.11.3. Product benchmarking
10.2.11.4. Strategic initiatives
10.2.12. Cell Signaling Technology, Inc.
10.2.12.1. Company overview
10.2.12.2. Financial performance
10.2.12.3. Product benchmarking
10.2.12.4. Strategic initiatives
10.2.13. Qsonica
10.2.13.1. Company overview
10.2.13.2. Financial performance
10.2.13.3. Product benchmarking
10.2.13.4. Strategic initiatives
10.2.14. BD
10.2.14.1. Company overview
10.2.14.2. Financial performance
10.2.14.3. Product benchmarking
10.2.14.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings